Decreased cognitive functioning in patients with advanced oral squamous cell carcinoma

Standard

Decreased cognitive functioning in patients with advanced oral squamous cell carcinoma. / Rohleder, Nils H; Wysluch, Andreas; Maurer, Peter; Wolff, Klaus-D; Wagenpfeil, Stefan; Kreutzer, Kilian; Hasler, Rafael; Wales, Craig J; Kesting, Marco R.

in: ORAL ONCOL, Jahrgang 47, Nr. 10, 10.2011, S. 993-7.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Rohleder, NH, Wysluch, A, Maurer, P, Wolff, K-D, Wagenpfeil, S, Kreutzer, K, Hasler, R, Wales, CJ & Kesting, MR 2011, 'Decreased cognitive functioning in patients with advanced oral squamous cell carcinoma', ORAL ONCOL, Jg. 47, Nr. 10, S. 993-7. https://doi.org/10.1016/j.oraloncology.2011.08.011

APA

Rohleder, N. H., Wysluch, A., Maurer, P., Wolff, K-D., Wagenpfeil, S., Kreutzer, K., Hasler, R., Wales, C. J., & Kesting, M. R. (2011). Decreased cognitive functioning in patients with advanced oral squamous cell carcinoma. ORAL ONCOL, 47(10), 993-7. https://doi.org/10.1016/j.oraloncology.2011.08.011

Vancouver

Rohleder NH, Wysluch A, Maurer P, Wolff K-D, Wagenpfeil S, Kreutzer K et al. Decreased cognitive functioning in patients with advanced oral squamous cell carcinoma. ORAL ONCOL. 2011 Okt;47(10):993-7. https://doi.org/10.1016/j.oraloncology.2011.08.011

Bibtex

@article{c51f760382e349e9b133781b9d11f2de,
title = "Decreased cognitive functioning in patients with advanced oral squamous cell carcinoma",
abstract = "Cognitive impairment causes a delay in diagnosis and treatment of the various cancer entities, resulting in reduced surgical outcomes and patient survival. However, no investigations have been carried out as to whether an association exists between cognitive functioning and tumour size in patients with oral squamous cell carcinoma (OSCC). In this study, 46 patients with OSCC were evaluated by using a screening test for dementia, consisting of a combination of the mini-mental state examination and the clock test (81% sensitivity and 90% specificity). Test scores were correlated with tumour size according to the TNM staging system, which was categorized as being either limited (T1, T2; n=24) or advanced (T3, T4; n=22). No difference in age (P=0.172), sex (P=0.330), the percentage of drinkers (P=0.090) or the percentage of smokers (P=0.484) was evident between the groups. Patients with advanced tumour size scored significantly lower (median 5.5 of 9 possible points) when compared with those having tumours of a limited size (median 9 of 9 possible points; P=0.005). The median score of patients with T3/T4 tumours suggested the need for comprehensive neuropsychological evaluations for dementia. In conclusion, this study has demonstrated the correlation of reduced cognitive functioning in patients with advanced OSCC. As a consequence, instructions for the identification of early signs and of symptoms of oral cancer are strongly recommended for relatives and nursing staff of patients with cognitive impairment. Such patients might need immediate treatment for oral cancer but might not be able to understand the significance of their symptoms and therefore present late, often too late.",
keywords = "Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell, Dementia, Female, Humans, Male, Middle Aged, Mouth Neoplasms, Neoplasm Staging, Neuropsychological Tests, Risk Factors, Sensitivity and Specificity",
author = "Rohleder, {Nils H} and Andreas Wysluch and Peter Maurer and Klaus-D Wolff and Stefan Wagenpfeil and Kilian Kreutzer and Rafael Hasler and Wales, {Craig J} and Kesting, {Marco R}",
note = "Copyright {\textcopyright} 2011 Elsevier Ltd. All rights reserved.",
year = "2011",
month = oct,
doi = "10.1016/j.oraloncology.2011.08.011",
language = "English",
volume = "47",
pages = "993--7",
journal = "ORAL ONCOL",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "10",

}

RIS

TY - JOUR

T1 - Decreased cognitive functioning in patients with advanced oral squamous cell carcinoma

AU - Rohleder, Nils H

AU - Wysluch, Andreas

AU - Maurer, Peter

AU - Wolff, Klaus-D

AU - Wagenpfeil, Stefan

AU - Kreutzer, Kilian

AU - Hasler, Rafael

AU - Wales, Craig J

AU - Kesting, Marco R

N1 - Copyright © 2011 Elsevier Ltd. All rights reserved.

PY - 2011/10

Y1 - 2011/10

N2 - Cognitive impairment causes a delay in diagnosis and treatment of the various cancer entities, resulting in reduced surgical outcomes and patient survival. However, no investigations have been carried out as to whether an association exists between cognitive functioning and tumour size in patients with oral squamous cell carcinoma (OSCC). In this study, 46 patients with OSCC were evaluated by using a screening test for dementia, consisting of a combination of the mini-mental state examination and the clock test (81% sensitivity and 90% specificity). Test scores were correlated with tumour size according to the TNM staging system, which was categorized as being either limited (T1, T2; n=24) or advanced (T3, T4; n=22). No difference in age (P=0.172), sex (P=0.330), the percentage of drinkers (P=0.090) or the percentage of smokers (P=0.484) was evident between the groups. Patients with advanced tumour size scored significantly lower (median 5.5 of 9 possible points) when compared with those having tumours of a limited size (median 9 of 9 possible points; P=0.005). The median score of patients with T3/T4 tumours suggested the need for comprehensive neuropsychological evaluations for dementia. In conclusion, this study has demonstrated the correlation of reduced cognitive functioning in patients with advanced OSCC. As a consequence, instructions for the identification of early signs and of symptoms of oral cancer are strongly recommended for relatives and nursing staff of patients with cognitive impairment. Such patients might need immediate treatment for oral cancer but might not be able to understand the significance of their symptoms and therefore present late, often too late.

AB - Cognitive impairment causes a delay in diagnosis and treatment of the various cancer entities, resulting in reduced surgical outcomes and patient survival. However, no investigations have been carried out as to whether an association exists between cognitive functioning and tumour size in patients with oral squamous cell carcinoma (OSCC). In this study, 46 patients with OSCC were evaluated by using a screening test for dementia, consisting of a combination of the mini-mental state examination and the clock test (81% sensitivity and 90% specificity). Test scores were correlated with tumour size according to the TNM staging system, which was categorized as being either limited (T1, T2; n=24) or advanced (T3, T4; n=22). No difference in age (P=0.172), sex (P=0.330), the percentage of drinkers (P=0.090) or the percentage of smokers (P=0.484) was evident between the groups. Patients with advanced tumour size scored significantly lower (median 5.5 of 9 possible points) when compared with those having tumours of a limited size (median 9 of 9 possible points; P=0.005). The median score of patients with T3/T4 tumours suggested the need for comprehensive neuropsychological evaluations for dementia. In conclusion, this study has demonstrated the correlation of reduced cognitive functioning in patients with advanced OSCC. As a consequence, instructions for the identification of early signs and of symptoms of oral cancer are strongly recommended for relatives and nursing staff of patients with cognitive impairment. Such patients might need immediate treatment for oral cancer but might not be able to understand the significance of their symptoms and therefore present late, often too late.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Carcinoma, Squamous Cell

KW - Dementia

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Mouth Neoplasms

KW - Neoplasm Staging

KW - Neuropsychological Tests

KW - Risk Factors

KW - Sensitivity and Specificity

U2 - 10.1016/j.oraloncology.2011.08.011

DO - 10.1016/j.oraloncology.2011.08.011

M3 - SCORING: Journal article

C2 - 21903447

VL - 47

SP - 993

EP - 997

JO - ORAL ONCOL

JF - ORAL ONCOL

SN - 1368-8375

IS - 10

ER -